Average positivity rates for OLIG2 were 7% (range 4–10%) in GC-GBM and 77% (range 55–94%) in MS-GBM; the positivity rate was significantly lower in GC-GBM compared with MS-GBM (P < 0.01) (Table 1). This evidence concerns the gene OLIG2 and glioblastoma.